VERSAPRO™ CREAM BASE

Products > Bases > Creams / Lotions > VERSAPRO™ CREAM BASE

OVERVIEW
BUD
PRODUCT DETAILS
QUESTIONS

VERSAPRO™ CREAM BASE

Product No: 2529

Description: MEDISCA’s VersaPro™ Cream Base has combined science and innovation to deliver a pharmaceutically elegant product. This unique, white, oil-in-water formulation exhibits strong drug compatibility and permeation, as well as non-comedogenic and hypoallergenic properties, rendering it ideal for both pharmaceutical and cosmetic purposes. Free of MI/MCI and parabens.

Price: -

Size

Qty

Cream Base Reference Chart DOWNLOAD

FLY-BASE_VersaPro Cream_Sell Sheet MUS - V01 DIGITAL DOWNLOAD

Lot Number and Batch Explanation DOWNLOAD

SDS DOWNLOAD

Allergen BSE GMO Declaration_base_2529_v1 DOWNLOAD

Do you have any questions regarding this product or do you need an offer customized for your needs?
Simply complete the form below and we will get back to you as soon as possible.

Name
E-Mail
Pharmacy Name
Phone Number
Comments

Additional Resources

Cream Base Reference Chart FLY-BASE_VersaPro Cream_Sell Sheet MUS - V01 DIGITAL Lot Number and Batch Explanation SDS Allergen BSE GMO Declaration_base_2529_v1

Research & Development.

We thought a lot about what goes into our bases, so you wouldn't have to.

See details

Scientific Data	- Increased permeation of Progesterone through the skin (DPSI, January 2010) – Validated Beyond-Use-Dates (BUDs) Available – Scientifically Classified as an All-Day Moisturizer
API Compatibility	For lipophilic and hydrophilic drugs (hormones, analgesics, etc.)
Appearance	White, smooth, versatile cream
Intended Use	– Pharmaceutical : Highly penetrating transdermal delivery vehicle – Cosmetic : Non-comedogenic moisturizer containing Vitamin E and Aloe Vera
pH Stability	pH 2 to 12
Tolerance to API Base & Salt Forms	Excellent
Application to Mucous Membranes	Yes
Heat Sensitivity	Stable at 40°C (104°F)
Preservatice Effectiveness	Passes USP microbial challenge test <51>

Topical BUD Databank

BUD (Beyond-Use Date) studies provide important information on the stability of a compounded preparation. We've partnered with well-renowned, third-party institutions throughout Canada and the US to conduct our studies. Our new BUD databank is stability-indicating and bracketed to provide flexibility for pharmacists.

View Studies Performed

FORMULA NUMBER	API	BASE	BUD
F 009 529	Benzocaine 20%, Lidocaine 6%, Tetracaine 4%	VERSAPRO CREAM BASE	180 days at RT
F 009 715	Cyclobenzaprine Hydrochloride 5%, Diclofenac Sodium 10%, Lidocaine 5%	VERSAPRO CREAM BASE	180 days at RT
F 008 949v2	DHEA 0.2%-4%, Estradiol 0.01%-0.2%, Estriol 0.04%-0.8%, Progesterone 1%-20%, Testosterone 0.025%-0.5% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 008 945v2	Diclofenac Sodium 1%-15% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 008 342v2	Estradiol 0.01%-10% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 008 991v2	Estradiol 0.025%-0.25%, Estriol 0.025%-0.25%, Testosterone 1%-10% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 008 995v2	Estradiol 0.025%-0.5%, Estriol 0.025%-0.5%, Progesterone 1%-20% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 008 993v2	Estradiol 0.025%-0.5%, Estriol 0.1%-2% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 008 341v2	Estriol 0.01%-10% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 009 687	Ketamine 0.5%-8.5% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 009 559	Ketoprofen 2.5%-30% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 008 567v2	Progesterone 1%-40% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT
F 009 190v2	Testosterone 0.02%-25% (Bracketed)	VERSAPRO CREAM BASE	180 days at RT

VERSAPRO™ CREAM BASE

VERSAPRO™ CREAM BASE

Additional Resources

Research & Development.

Topical BUD Databank

Thank you for your interest in our ORA Products!

Thank you for your interest in our Diffusimax Products!

STAY CONNECTED